Overall rank by patents
#43,209
of 49,997 tracked assignees
USPTO PatentsView assignee record - 6 granted patents across 2 technology areas, recorded in grant years 2022–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor).
The verdict
According to USPTO PatentsView, Solteam ranks #43,209 of 49,997 tracked US assignees by granted-patent volume, with 6 patents across 2 technology areas.
USPTO PatentsView assignee plate
Corpus R43209 · Foreign Corporation #43,209 · 6 grants
GRANTS-MICRO · LOWER-Q · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-PAR · TYPE-FRNCORP · SPAN-YRS · BOOK-RICH
Nearest grant-volume peer: Solentim Ltd. (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
Qualcomm Incorporated · highest
85 score
Solteam Incorporation · this assignee
37 score
3D Lighting… · lowest
7 score
What this shows Solteam's Innovation Score is 36.8/100 (top 45% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Solteam Incorporation is a focused PatentsView assignee: 2 CPC subclasses with 33.3% of grants classified under A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor). Peak complete grant year is 2022 (3 grants) versus a trough of 2 in 2023. By volume, Solteam sits between Solentim Ltd. and Sonoscape Medical Corp..
Solteam Incorporation shows 5 grants in 2022–2024 against only 0 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
Solentim Ltd.
6 patents
Solgix, Inc
6 patents
Solid Carbon Products, LLC
6 patents
Solon Manufacturing Company
6 patents
Solution Seeker AS
6 patents
Solvay Fluor GMBH
6 patents
Sonarmed Inc.
6 patents
Sonoscape Medical Corp.
6 patents
Solteam Incorporation
6 patents
What this shows Solteam holds 6 patents at rank #42,946, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #42,946 in granted patent volume.
Other assignees with the most granted patents in Solteam's primary technology class.
Solteam's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
37 Top 45% higher than 55% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2022–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2022 | 3 | 50.0% |
| 2023 | 2 | 33.3% |
| 2025partial year | 1 | 16.7% |
Top 2 of 2 technology areas
Overall rank by patents
#43,209
of 49,997 tracked assignees
36.8 out of 100
What to do with this data
Solteam Incorporation's patent record in context - here's where to go next.
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.